The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Proliferating dendritic cell progenitors in human blood.
Open accessAbstract
CD34+ cells in human cord blood and marrow are known to give rise to dendritic cells (DC), as well as to other myeloid lineages. CD34+ cells are rare in adult blood, however, making it difficult to use CD34+ cells to ascertain if DC progenitors are present in the circulation and if blood can be a starting point to obtain large numbers of these immunostimulatory antigen-presenting cells for clinical studies. A systematic search for DC progenitors was therefore carried out in several contexts. In each case, we looked initially for the distinctive proliferating aggregates that were described previously in mice. In cord blood, it was only necessary to deplete erythroid progenitors, and add granulocyte/macrophage colony-stimulating factor (GM-CSF) together with tumor necrosis factor (TNF), to observe many aggregates and the production of typical DC progeny. In adult blood from patients receiving CSFs after chemotherapy for malignancy, GM-CSF and TNF likewise generated characteristic DCs from HLA-DR negative precursors. However, in adult blood from healthy donors, the above approaches only generated small DC aggregates which then seemed to become monocytes. When interleukin 4 was used to suppress monocyte development (Jansen, J. H., G.-J. H. M. Wientjens, W. E. Fibbe, R. Willemze, and H. C. Kluin-Nelemans. 1989. J. Exp. Med. 170:577.), the addition of GM-CSF led to the formation of large proliferating DC aggregates and within 5-7 d, many nonproliferating progeny, about 3-8 million cells per 40 ml of blood. The progeny had a characteristic morphology and surface composition (e.g., abundant HLA-DR and accessory molecules for cell-mediated immunity) and were potent stimulators of quiescent T cells. Therefore, large numbers of DCs can be mobilized by specific cytokines from progenitors in the blood stream. These relatively large numbers of DC progeny should facilitate future studies of their Fc epsilon RI and CD4 receptors, and their use in stimulating T cell-mediated resistance to viruses and tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Self-citationGerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
Self-citationGM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
Caux, C., Dezutter-Dambuyant, C., Schmitt, D., & Banchereau, J. (1992) · Nature · doi:10.1038/360258a0 · Cited by 1,554
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., Lustig, D. S., & Cohn, Z. A. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.6.1431 · Cited by 1,050
Self-citationEpidermal Langerhans cells are derived from cells originating in bone marrow
Katz, S. I., Tamaki, K., & Sachs, D. H. (1979) · Nature · doi:10.1038/282324a0 · Cited by 888
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., & Cohn, Z. A. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.2.380 · Cited by 814
Self-citationInaba, K., Metlay, J. P., Crowley, M. T., & Steinman, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.2.631 · Cited by 657
Self-citationHeufler, C., Koch, F., & Schuler, G. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.700 · Cited by 540
Self-citationWitmer-Pack, M. D., Olivier, W., Valinsky, J., Schuler, G., & Steinman, R. M. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1484 · Cited by 506
Self-citation
Cited by
Items 101–153 of 153
Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production
Ho, L.-J., Wang, J.-J., Shaio, M.-F., Kao, C.-L., Chang, D.-M., Han, S.-W., & Lai, J.-H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1499 · Cited by 314
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines
Caux, C., Ait-Yahia, S., Chemin, K., de Bouteiller, O., Dieu-Nosjean, M.-C., Homey, B., Massacrier, C., Vanbervliet, B., Zlotnik, A., & Vicari, A. (2000) · Springer Seminars in Immunopathology · doi:10.1007/s002810000053 · Cited by 313
CD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair
Van Kooten, C., & Banchereau, J. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60865-2 · Cited by 311
Dendritic cells: from ontogenetic orphans to myelomonocytic descendants
Peters, J. H., Gieseler, R., Thiele, B., & Steinbach, F. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80544-5 · Cited by 311
Generation of Mature Dendritic Cells from Human Blood
Schuler, G., & Romani, N. (1997) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-9966-8_2 · Cited by 309
Self-citationDendritic cells capable of stimulating T cells in germinal centres
Grouard, G., Durand, I., Filgueira, L., Banchereau, J., & Liu, Y.-J. (1996) · Nature · doi:10.1038/384364a0 · Cited by 299
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
Hamdy, S., Haddadi, A., Hung, R. W., & Lavasanifar, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.021 · Cited by 298
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Batich, K. A., Reap, E. A., Archer, G. E., Sanchez-Perez, L., Nair, S. K., Schmittling, R. J., Norberg, P., Xie, W., Herndon, J. E., Healy, P., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2057 · Cited by 295
Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells
Bauer, M., Redecke, V., Ellwart, J. W., Scherer, B., Kremer, J.-P., Wagner, H., & Lipford, G. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5000 · Cited by 293
Autoimmunity through Cytokine-Induced Dendritic Cell Activation
Banchereau, J., Pascual, V., & Palucka, A. K. (2004) · Immunity · doi:10.1016/s1074-7613(04)00108-6 · Cited by 293
Some interfaces of dendritic cell biology
STEINMAN, R. M. (2003) · APMIS · doi:10.1034/j.1600-0463.2003.11107802.x · Cited by 292
Self-citationHilkens, C. M. U., Kalinski, P., de Boer, M., & Kapsenberg, M. L. (1997) · Blood · doi:10.1182/blood.v90.5.1920 · Cited by 292
Hashimi, S. T., Fulcher, J. A., Chang, M. H., Gov, L., Wang, S., & Lee, B. (2009) · Blood · doi:10.1182/blood-2008-09-179150 · Cited by 291
Origin and differentiation of dendritic cells
Ardavı́n, C., Martı́nez del Hoyo, G., Martı́n, P., Anjuère, F., Arias, C. F., Marı́n, A. R., Ruiz, S., Parrillas, V., & Hernández, H. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02059-2 · Cited by 291
Transcriptomic analyses of murine resolution-phase macrophages
Stables, M. J., Shah, S., Camon, E. B., Lovering, R. C., Newson, J., Bystrom, J., Farrow, S., & Gilroy, D. W. (2011) · Blood · doi:10.1182/blood-2011-04-345330 · Cited by 291
Allergic Contact Dermatitis––Formation, Structural Requirements, and Reactivity of Skin Sensitizers
Karlberg, A.-T., Bergström, M. A., Börje, A., Luthman, K., & Nilsson, J. L. G. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7002239 · Cited by 287
Dendritic cells: On the move from bench to bedside
Nestle, F. O., Banchereau, J., & Hart, D. (2001) · Nature Medicine · doi:10.1038/89863 · Cited by 287
Immunotherapy of cancer with dendritic-cell-based vaccines
Gilboa, E., Nair, S. K., & Lyerly, H. K. (1998) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050465 · Cited by 287
Choudhury, A., Gajewski, J. L., Liang, J. C., Popat, U., Claxton, D. F., Kliche, K.-O., Andreeff, M., & Champlin, R. E. (1997) · Blood · doi:10.1182/blood.v89.4.1133 · Cited by 285
Valladeau, J., Duvert-Frances, V., Pin, J.-J., Dezutter-Dambuyant, C., Vincent, C., Massacrier, C., Vincent, J., Yoneda, K., Banchereau, J., Caux, C., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<2695::aid-immu2695>3.0.co;2-q · Cited by 283
Power, C. A., Church, D. J., Meyer, A., Alouani, S., Proudfoot, A. E. I., Clark-Lewis, I., Sozzani, S., Mantovani, A., & Wells, T. N. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.6.825 · Cited by 282
Direct exosome stimulation of peripheral humanT cells detected by ELISPOT
Admyre, C., Johansson, S. M., Paulie, S., & Gabrielsson, S. (2006) · European Journal of Immunology · doi:10.1002/eji.200535615 · Cited by 281
Young, J. W., Szabolcs, P., & Moore, M. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.1111 · Cited by 277
Bell, D., Young, J. W., & Banchereau, J. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60023-1 · Cited by 277
Rieser, C., Böck, G., Klocker, H., Bartsch, G., & Thurnher, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1603 · Cited by 274
Mesoporous Silica Particles Induce Size Dependent Effects on Human Dendritic Cells
Vallhov, H., Gabrielsson, S., Strømme, M., Scheynius, A., & Garcia-Bennett, A. E. (2007) · Nano Letters · doi:10.1021/nl0714785 · Cited by 270
Bates, E. E. M., Fournier, N., Garcia, E., Valladeau, J., Durand, I., Pin, J.-J., Zurawski, S. M., Patel, S., Abrams, J. S., Lebecque, S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1973 · Cited by 269
Young, J. W., & Inaba, K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.7 · Cited by 269
Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
Steinman, R. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.001 · Cited by 268
Self-citationModulating the immune response with dendritic cells and their growth factors
Pulendran, B., Banchereau, J., Maraskovsky, E., & Maliszewski, C. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01794-4 · Cited by 263
Estrogen Receptor Signaling in the Immune System
Chakraborty, B., Byemerwa, J., Krebs, T., Lim, F., Chang, C.-Y., & McDonnell, D. P. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac017 · Cited by 263
Paquette, R. L., Hsu, N. C., Kiertscher, S. M., Park, A. N., Tran, L., Roth, M. D., & Glaspy, J. A. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.358 · Cited by 262
MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines
Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Magarian‐Blander, J., & Barratt‐Boyes, S. M. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00077.x · Cited by 261
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
Lübbers, J., Rodríguez, E., & van Kooyk, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02807 · Cited by 260
An Overview of Cancer Treatment Modalities
Abbas, Z., & Rehman, S. (2018) · Neoplasm · doi:10.5772/intechopen.76558 · Cited by 258
Development of interleukin-12-producing capacity throughout childhood
Upham, J. W., Lee, P. T., Holt, B. J., Heaton, T., Prescott, S. L., Sharp, M. J., Sly, P. D., & Holt, P. G. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6583-6588.2002 · Cited by 257
Riol-Blanco, L., Sánchez-Sánchez, N., Torres, A., Tejedor, A., Narumiya, S., Corbí, A. L., Sánchez-Mateos, P., & Rodríguez-Fernández, J. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4070 · Cited by 257
Willment, J. A., Marshall, A. S. J., Reid, D. M., Williams, D. L., Wong, S. Y. C., Gordon, S., & Brown, G. D. (2005) · European Journal of Immunology · doi:10.1002/eji.200425725 · Cited by 257
Zhao, X., Yang, K., Zhao, R., Ji, T., Wang, X., Yang, X., Zhang, Y., Cheng, K., Liu, S., Hao, J., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.032 · Cited by 256
Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.
Mayordomo, J. I., Loftus, D. J., Sakamoto, H., De Cesare, C. M., Appasamy, P. M., Lotze, M. T., Storkus, W. J., Appella, E., & DeLeo, A. B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1357 · Cited by 253
Saunders, D., Lucas, K., Ismaili, J., Wu, L., Maraskovsky, E., Dunn, A., & Shortman, K. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2185 · Cited by 252
MILLARD, A. L., MERTES, P. M., ITTELET, D., VILLARD, F., JEANNESSON, P., & BERNARD, J. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.0009-9104.2002.01977.x · Cited by 220
Granelli-Piperno, A., Pritsker, A., Pack, M., Shimeliovich, I., Arrighi, J.-F., Park, C. G., Trumpfheller, C., Piguet, V., Moran, T. M., & Steinman, R. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4265 · Cited by 208
Self-citationLewinsohn, D. M., Alderson, M. R., Briden, A. L., Riddell, S. R., Reed, S. G., & Grabstein, K. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1633 · Cited by 165
Sato, K., Kawasaki, H., Nagayama, H., Enomoto, M., Morimoto, C., Tadokoro, K., Juji, T., & Takahashi, T. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2285 · Cited by 152
Zhao, T., Ren, H., Jia, L., Chen, J., Xin, W., Yan, F., Li, J., Wang, X., Gao, S., Qian, D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2948 · Cited by 142
“DCs were generated from the adherent fraction of PBMCs [48].”
MethodMigration of dendritic cell based cancer vaccines: in vivo veritas?
Adema, G. J., de Vries, I. J. M., Punt, C. J., & Figdor, C. G. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.01.004 · Cited by 134
Michiels, A., Tuyaerts, S., Bonehill, A., Corthals, J., Breckpot, K., Heirman, C., Van Meirvenne, S., Dullaers, M., Allard, S., Brasseur, F., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302471 · Cited by 93
St. Louis, D. C., Woodcock, J. B., Fransozo, G., Blair, P. J., Carlson, L. M., Murillo, M., Wells, M. R., Williams, A. J., Smoot, D. S., Kaushal, S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3237 · Cited by 87
Dendritic cell responses to surface properties of clinical titanium surfaces
Kou, P. M., Schwartz, Z., Boyan, B. D., & Babensee, J. E. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.10.020 · Cited by 73
Davis, T. A., Saini, A. A., Blair, P. J., Levine, B. L., Craighead, N., Harlan, D. M., June, C. H., & Lee, K. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3689 · Cited by 70
Pei, Q., Pan, J., Zhu, H., Ding, X., Liu, W., Lv, Y., Zou, X., & Luo, H. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2013.12.022 · Cited by 31
Hryhorenko, E. A., Oseroff, A. R., Morgan, J., & Rittenhouse-Diakun, K. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00047-2 · Cited by 30
Metadata
- Authors
- Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-07-01
- Volume
- 180
- Issue
- 1
- Pages
- 83-93
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2124376809
- Cited by
- 1,840
- References
- 37
- FWCI
- 31.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.